BioSpace News Archive

SPR Therapeutics announced today that two presentations highlighting SPRINT® PNS in treating chronic pain will be featured at the American Society of Pain & Neuroscience (ASPN) conference July 14-17.

ZOLL® Medical Corporation, an Asahi Kasei company that manufactures medical devices and related software solutions, announced that the Centers for Medicare & Medicaid Services ICD-10 Coordination and Maintenance Committee has issued a new ICD-10-PCS code for TherOx® SuperSaturated Oxygen Therapy.

Accelus, a privately held medical technology company focused on accelerating the adoption of minimally invasive surgery (MIS) as the standard of care in spine, today announced Vail-Summit Orthopaedics and Neurosurgery (VSON) as the first ambulatory surgery center (ASC) to acquire the Remi Robotic Navigation System.

Enveda Biosciences, a pioneer in transforming small molecule drug discovery by using machine learning and metabolomics to harness the potential of natural products, announced the appointment of Vanitha Sekar, Ph.D., R.Ph., to the newly created position of Chief Business Officer.

According to a latest report by Reports and Data, the cyclotron market size is expected to reach USD 359.8 million in 2030 and register a revenue CAGR of 5.1% over the forecast period.

The latest market analysis report published by Reports and Data, titled ‘Global Ivermectin Market – Forecast to 2030,’ thoroughly examines the Ivermectin industry to provide essential data & information for the targeted readers.

According to the current analysis of Reports and Data, the global Population Health Management (PHM) market was valued at USD 24.82 Billion in 2021 and is expected to reach USD 74.61 Billion by year 2030, at a CAGR of 13.0%.

Leaders from public and private universities, businesses, nonprofits, trade associations and state government have joined forces to bring the new Advanced Research Projects Agency for Health headquarters to North Carolina.

Sharps Technology, Inc. (the “Company”) (NASDAQ: “STSS” and “STSSW”), an innovative medical device company offering patented, best-in-class, single use smart safety syringe products, is pleased to announce the Company completed its acquisition of Safegard Medical’s syringe manufacturing facility in Hungary.

Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that it will report second quarter 2022 financial results after the Nasdaq market closes on Thursday, August 4, 2022.